Janus registry results
This article was originally published in The Gray Sheet
Executive Summary
Six-month clinical results from Sorin Group's e-Janus international "real-world" registry - which has thus far enrolled over 2,500 patients at more than 80 centers worldwide - show a 4.3% major adverse cardiac events (MACE) rate and a 3.1% target lesion revascularization (TLR) rate for the 587 patients for which data has been collected. For the approximately 133 cases of high-risk acute myocardial infarction, a 3% MACE rate, 2.2% TLR rate and 0% late stent thrombosis rate were reported...